RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
RBC Bioscience - Stock

RBC Bioscience Debt 2024

RBC Bioscience Debt

406.47 TWD

Ticker

6848.TWO

ISIN

TW0006848005

In 2024, RBC Bioscience's total debt was 406.47 TWD, a 0.16% change from the 405.82 TWD total debt recorded in the previous year.

RBC Bioscience Aktienanalyse

What does RBC Bioscience do?

RBC Bioscience ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding RBC Bioscience's Debt Structure

RBC Bioscience's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing RBC Bioscience's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to RBC Bioscience’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in RBC Bioscience’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about RBC Bioscience Stock

What is the debt of RBC Bioscience this year?

RBC Bioscience has a debt level of 406.47 TWD this year.

What was the debt of RBC Bioscience compared to the previous year?

The debt of RBC Bioscience has increased by 0.16% compared to the previous year increased.

What are the consequences of high debt for investors in RBC Bioscience?

High debt can pose a risk for investors of RBC Bioscience, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of RBC Bioscience?

Low debt means that RBC Bioscience has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from RBC Bioscience affect the company?

An increase in debt of RBC Bioscience can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of RBC Bioscience affect the company?

A reduction in debt of RBC Bioscience can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of RBC Bioscience?

Some factors that can influence the debt of RBC Bioscience include investments, acquisitions, operating costs, and revenue development.

Why are the debts of RBC Bioscience so important for investors?

The debts of RBC Bioscience are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can RBC Bioscience take to change the debt?

To change the debt, RBC Bioscience can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does RBC Bioscience pay?

Over the past 12 months, RBC Bioscience paid a dividend of 1.12 TWD . This corresponds to a dividend yield of about 6.59 %. For the coming 12 months, RBC Bioscience is expected to pay a dividend of 1.12 TWD.

What is the dividend yield of RBC Bioscience?

The current dividend yield of RBC Bioscience is 6.59 %.

When does RBC Bioscience pay dividends?

RBC Bioscience pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of RBC Bioscience?

RBC Bioscience paid dividends every year for the past 2 years.

What is the dividend of RBC Bioscience?

For the upcoming 12 months, dividends amounting to 1.12 TWD are expected. This corresponds to a dividend yield of 6.59 %.

In which sector is RBC Bioscience located?

RBC Bioscience is assigned to the 'Health' sector.

Wann musste ich die Aktien von RBC Bioscience kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of RBC Bioscience from 8/11/2023 amounting to 1.12 TWD, you needed to have the stock in your portfolio before the ex-date on 7/13/2023.

When did RBC Bioscience pay the last dividend?

The last dividend was paid out on 8/11/2023.

What was the dividend of RBC Bioscience in the year 2023?

In the year 2023, RBC Bioscience distributed 0.909 TWD as dividends.

In which currency does RBC Bioscience pay out the dividend?

The dividends of RBC Bioscience are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von RBC Bioscience

Our stock analysis for RBC Bioscience Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of RBC Bioscience Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.